These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30048924)

  • 1. Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]
    Purushothaman B; Arumugam P; Ju H; Kulsi G; Samson AAS; Song JM
    Eur J Med Chem; 2018 Aug; 156():747-759. PubMed ID: 30048924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
    Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
    J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new bis-pyrazolylpyridine ruthenium(III) complex as a potential anticancer drug:
    Lazić D; Scheurer A; Ćoćić D; Milovanović J; Arsenijević A; Stojanović B; Arsenijević N; Milovanović M; Rilak Simović A
    Dalton Trans; 2021 Jun; 50(22):7686-7704. PubMed ID: 33982702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Aryl-1
    Kar B; Shanavas S; Karmakar A; Nagendra AH; Vardhan S; Sahoo SK; Bose B; Kundu S; Paira P
    J Med Chem; 2024 Jul; 67(13):10928-10945. PubMed ID: 38812379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cells.
    Deng Z; Gao P; Yu L; Ma B; You Y; Chan L; Mei C; Chen T
    Biomaterials; 2017 Jun; 129():111-126. PubMed ID: 28340357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dinuclear Organoruthenium Complex for Mitochondria-Targeted Near-Infrared Imaging and Anticancer Therapy to Overcome Platinum Resistance.
    Wang J; Zhang Y; Li Y; Li E; Ye W; Pan J
    Inorg Chem; 2022 May; 61(21):8267-8282. PubMed ID: 35584546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mode of action of NKP-1339 - a clinically investigated ruthenium-based drug - involves ER- and ROS-related effects in colon carcinoma cell lines.
    Flocke LS; Trondl R; Jakupec MA; Keppler BK
    Invest New Drugs; 2016 Jun; 34(3):261-8. PubMed ID: 26988975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.
    Chen L; Li G; Peng F; Jie X; Dongye G; Cai K; Feng R; Li B; Zeng Q; Lun K; Chen J; Xu B
    Oncotarget; 2016 Dec; 7(49):80716-80734. PubMed ID: 27811372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo.
    Savic M; Arsenijevic A; Milovanovic J; Stojanovic B; Stankovic V; Rilak Simovic A; Lazic D; Arsenijevic N; Milovanovic M
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse Model.
    Miachin K; Del Solar V; El Khoury E; Nayeem N; Khrystenko A; Appelt P; Neary MC; Buccella D; Contel M
    Inorg Chem; 2021 Dec; 60(24):19152-19164. PubMed ID: 34846878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
    Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
    J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
    Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y
    J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity, cellular uptake, and subcellular localization of a nitrogen oxide and aminopropyl-β-lactose derivative ruthenium complex used as nitric oxide delivery agent.
    Dos Santos JS; Ramos LC; Ferreira LP; Campo VL; de Rezende LCD; da Silva Emery F; Santana da Silva R
    Nitric Oxide; 2019 May; 86():38-47. PubMed ID: 30790696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pH-Sensitive Nanocarrier for Tumor Targeting : Delivery of Ruthenium Complex for Tumor Theranostic by pH-Sensitive Nanocapsule.
    Chen L; Fu C; Deng Y; Wu W; Fu A
    Pharm Res; 2016 Dec; 33(12):2989-2998. PubMed ID: 27590630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η
    Poljarević JM; Tamás Gál G; May NV; Spengler G; Dömötör O; Savić AR; Grgurić-Šipka S; Enyedy ÉA
    J Inorg Biochem; 2018 Apr; 181():74-85. PubMed ID: 29407910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium complex delivery using liposomes to improve bioactivity against HeLa cells via the mitochondrial pathway.
    Guo B; Liao C; Fang Y; Li S; Li X; Lu Z; Chen Y
    Nanomedicine (Lond); 2018 Nov; 13(22):2851-2866. PubMed ID: 30457036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.